Teva UK Ltd and another v Astrazeneca AB [2014] EWHC 2873 (Pat), [2014] All ER (D) 44 (Sep)
The Patents Court considered challenges to the legitimacy of a patent for a treatment of asthma. It held that a challenge to the patent based on anticipation would be dismissed. However, a challenge to the patent on grounds of obviousness was made out and the patent was therefore invalid. A number of amended claims put forward by the owner of the patent would be rejected.
Nikki Bowker, head of dispute resolution at Devonshires, on career resilience, diversity in law and channelling Elle Woods when the pressure is on
Leasehold enfranchisement specialist joins residential property team
Firm strengthens commercial team in Manchester with partner appointment
An Italian financier has lost his bid to block his Australian wife from filing divorce papers in England on the basis it was no longer her domicile of choice
